Related by context. Frequent words. (Click for all words.) 82 Onalta 74 Receives Orphan Drug Designation 71 Meets Primary Endpoint 71 Drug Candidate 70 Initiates Phase II 69 Pivotal Phase III 69 Phase III Clinical Trial 69 Announces FDA Clearance 69 phenylketonuria PKU developed 69 Fast Track Status 69 Completes Enrollment 69 Small Molecule 69 Presents Positive 69 Single Dose 69 Patient Enrollment 68 Inhalation Aerosol 68 pseudobulbar affect PBA 68 inflammatory autoimmune diseases 68 Enrolls First 68 Recombinant Human 68 Lipid Polymer Micelle LPM 68 Develop Novel 68 Monoclonal Antibody 68 FDA Accepts 67 topical anti infective 67 R sorafenib tablets 67 Kuvan R 67 Epratuzumab 67 Receives FDA Clearance 67 FDA Clears 67 Preclinical Data 67 Clinical Trial Results 67 Tesetaxel 67 MKC# 67 Generic Version 67 Flagship Product 67 Panzem R 66 Ciclesonide 66 dipropionate 66 Daclizumab 66 Potassium Chloride Sodium Ascorbate 66 candidate AP# 66 Improves Survival 66 BY JASON THOMPSON 66 refractory chronic lymphocytic 66 Advancing Drugs 66 Nexavar ® 66 Copegus R 66 Racivir 66 Commences Phase 66 ALN TTR# 66 Metastatic Melanoma 65 Pivotal Phase 65 Locteron ® 65 CHEAP ONLINE PHARMACY LOW 65 Inc Therapeutic Competitors 65 novel RNAi therapeutics 65 Sapacitabine 65 RNAi Therapeutics 65 investigational mTOR inhibitor 65 Microplasmin 65 Microspheres 65 Benign Prostatic Hyperplasia 65 Lubiprostone 65 Well Tolerated 65 Cetrorelix 65 pramlintide acetate injection 65 liposomal formulation 65 Dapagliflozin 65 NMP# R 65 Aloxi R 65 Epidermal Growth Factor Receptor 65 phenylalanine ammonia lyase 65 VALSTAR 65 aesthetic medicine BioLook 65 Initiates Phase 65 sodium Injection 65 av IDG News 65 Medarex logo 65 Announces Initiation 65 regarding Aethlon Medical 65 THAT ARE SUBJECT TO 65 IS NOT INDICATIVE OF 65 novel antibody therapeutics 65 Receives Patent 65 PEG PAL PEGylated recombinant 65 Azedra 65 TRANSDUR Sufentanil 65 StromaCel Inc. 65 R bortezomib 65 CHEAP ONLINE PHARMACY BEST 64 Phase III Trial 64 ALN TTR 64 fibrosis IPF 64 FDA Clearance 64 NEBIDO R 64 candidates bavituximab 64 therapeutic monoclonal antibodies 64 trading house.net AG 64 Topical Solution 64 Pre Owned Vehicle